We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
(+9%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$164M |
| 2 |
Microsoft
MSFT
|
+$157M |
| 3 |
Amazon
AMZN
|
+$75.7M |
| 4 |
Tesla
TSLA
|
+$50M |
| 5 |
GE HealthCare
GEHC
|
+$45.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$33M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$26.2M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$24.9M |
| 4 |
Fair Isaac
FICO
|
+$17M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.37% |
| 2 | Healthcare | 13.58% |
| 3 | Financials | 12.66% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Accel Entertainment
ACEL
$987M
| $677K | ﹤0.01% |
74,270
+1,299
| +2% | +$11.7K |
|
|
CTO
2302
CTO Realty Growth
CTO
$815M
| $675K | ﹤0.01% |
39,085
+8,030
| +26% | +$145K |
|
2303
Artesian Resources
ARTNA
$358M
| $670K | ﹤0.01% |
12,107
+226
| +2% | +$12.9K |
|
2304
MaxCyte
MXCT
$126M
| $669K | ﹤0.01% |
135,143
+7,072
| +6% | +$34.8K |
|
|
NSTG
2305
DELISTED
NanoString Technologies, Inc.
NSTG
| $665K | ﹤0.01% |
67,147
+4,312
| +7% | +$42.7K |
|
2306
Fate Therapeutics
FATE
$326M
| $664K | ﹤0.01% |
116,549
+2,608
| +2% | +$15.7K |
|
|
INDT
2307
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $663K | ﹤0.01% |
9,995
+558
| +6% | +$36.1K |
|
2308
Ivanhoe Electric
IE
$1.74B
| $659K | ﹤0.01% |
54,204
+40,990
| +310% | +$549K |
|
2309
Merchants Bancorp
MBIN
$2.49B
| $656K | ﹤0.01% |
25,184
+560
| +2% | +$15.5K |
|
|
BBUC
2310
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.04B
| $654K | ﹤0.01% |
32,986
+994
| +3% | +$19.9K |
|
2311
Luxfer Holdings
LXFR
$458M
| $653K | ﹤0.01% |
38,628
+794
| +2% | +$12.7K |
|
2312
Montauk Renewables
MNTK
$255M
| $652K | ﹤0.01% |
82,904
+3,291
| +4% | +$33.4K |
|
|
MRSN
2313
DELISTED
Mersana Therapeutics
MRSN
| $651K | ﹤0.01% |
6,334
+215
| +4% | +$30.2K |
|
|
TPIC
2314
DELISTED
TPI Composites
TPIC
| $650K | ﹤0.01% |
49,781
+2,370
| +5% | +$30.2K |
|
|
SWI
2315
DELISTED
SolarWinds Corporation Common Stock
SWI
| $649K | ﹤0.01% |
75,479
+1,084
| +1% | +$10.1K |
|
2316
Ardagh Metal Packaging
AMBP
$3.01B
| $648K | ﹤0.01% |
158,805
+15,218
| +11% | +$74.7K |
|
2317
Nurix Therapeutics
NRIX
$2.65B
| $647K | ﹤0.01% |
72,812
+2,045
| +3% | +$21.3K |
|
2318
Lyell Immunopharma
LYEL
$360M
| $642K | ﹤0.01% |
13,603
+442
| +3% | +$23.6K |
|
|
CSTR
2319
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $641K | ﹤0.01% |
42,297
+491
| +1% | +$8.2K |
|
2320
Mercer International
MERC
$39.8M
| $640K | ﹤0.01% |
65,454
+4,038
| +7% | +$45.5K |
|
2321
Capital City Bank Group
CCBG
$890M
| $639K | ﹤0.01% |
21,787
+525
| +2% | +$17.1K |
|
|
CTIC
2322
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $639K | ﹤0.01% |
152,126
+7,730
| +5% | +$40.1K |
|
2323
Allogene Therapeutics
ALLO
$694M
| $638K | ﹤0.01% |
129,232
+3,730
| +3% | +$23.9K |
|
|
INFA
2324
DELISTED
Informatica
INFA
| $638K | ﹤0.01% |
38,874
+2,963
| +8% | +$50.3K |
|
2325
El Pollo Loco
LOCO
$462M
| $635K | ﹤0.01% |
66,259
+2,531
| +4% | +$28.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
- RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
- RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
- RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
- RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
- RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.
Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.